• data exclusivity, the prohibition

• data exclusivity, the prohibition of use by generics of clinical test data
(usually supplied by the original patent holder), would be for five years after
marketing approval for the patented product. However, the Peru FTA
permitted the clock to start on the exclusivity period at the time of firstcountry
market approval if the second country approved the product within
six months of the date of first market approval.